Impact of low‐dose quetiapine‐use on glycosylated hemoglobin, triglyceride and cholesterol levels

OBJECTIVE: Quetiapine use at standard doses has been associated with hyperglycemia and dyslipidemia. However, whether even frequently prescribed low‐dose quetiapine results in significant metabolic disturbances remains unclear. Thus, this study aimed to investigate the association between off‐label,...

Descripción completa

Detalles Bibliográficos
Autores principales: Højlund, Mikkel, Støvring, Henrik, Andersen, Kjeld, Correll, Christoph U., Hallas, Jesper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099591/
https://www.ncbi.nlm.nih.gov/pubmed/36281759
http://dx.doi.org/10.1111/acps.13515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099591/
https://www.ncbi.nlm.nih.gov/pubmed/36281759
http://dx.doi.org/10.1111/acps.13515

Ejemplares similares